3 news items
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
COYA
3 Jun 24
from the manuscript was previously presented at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference and the 2024 Society
Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
COYA
9 May 24
at the Society of Neuroimmune Pharmacology conference. Coya has filed intellectual property on multiple uses of 4-HNE in ALS
Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
COYA
8 Apr 24
in ALS.
Dr. Appel previously presented 4-HNE biomarker data in March 2024 at the Society
- Prev
- 1
- Next